Medical Oncologist
Your treatment plan
AC-T vs TC: why some women get four cycles and others eight
Some women receive a shorter chemotherapy course and others a longer one because they are on different regimens chosen for different cancers. The main difference is whether a drug from the anthracycline family is included. This page explains, in general terms, what the regimens mean and what an oncologist weighs when choosing between them.
NG
Medically reviewed by Dr. Naresh GunduConsultant Medical Oncologist · MBBS, DNB (Internal Medicine), DM (Medical Oncology, AIIMS) · last reviewed September 2026, next review due September 2027
The short answer
Why do some women get four cycles and others eight?
Because they are on different regimens chosen for different cancers. A shorter course uses a taxane with an alkylating drug and leaves out the anthracycline family. A longer course adds an anthracycline and runs in two blocks. The choice reflects how much treatment a particular cancer needs, not how thorough a hospital is being.
What the letters stand for
Regimens are named by the initials of their drugs. The two most often compared in early breast cancer differ mainly in whether an anthracycline is included. That single difference explains most of the gap in length and in side effects.
Why the anthracycline matters
It adds meaningful benefit for some higher-risk cancers, and it also carries a small risk to the heart that builds with dose. Leaving it out is reasonable where the added benefit is small, and that is the judgement your oncologist is making.
What decides which you are offered
Node involvement, tumour size and grade, receptor and HER2 status, your heart health and your age. Two women with apparently similar cancers can reasonably be offered different regimens.
This page describes general principles only. The right regimen for you is a decision for your oncologist.Side by side
The two approaches, in general terms
Shorter, anthracycline-free course
Longer course including an anthracycline
Fewer cycles, finished sooner
More cycles, given in two blocks
No anthracycline heart risk
A small, dose-related heart risk to monitor
Often chosen for lower-risk disease
Often chosen where risk is higher
Hair loss still usual
Hair loss usual
Suits some women with heart concerns
Needs a heart check before starting
The decision
What your oncologist weighs
These factors, read together, point towards one approach or the other.
How much benefit is at stake
Where the cancer carries a higher risk of returning, the extra benefit of an anthracycline is worth its side effects. Where risk is lower, the balance can favour leaving it out.
Your heart
Existing heart disease, or a need for heart-affecting treatment later, can steer towards an anthracycline-free option. A heart scan is often done before deciding.
Mention any heart history at the first appointment.The subtype
Receptor status and HER2 result change the whole shape of treatment. HER2 positive cancers, for example, are treated with additional targeted therapy, which influences regimen choice.
Your age and general health
How well you are likely to tolerate a longer course, and what other conditions you have, both feed into the recommendation.
Ask your oncologist
- Why this regimen for me
- What would change the choice
- Will my heart be checked
Talk to our team
Have a question about your situation?
Call the helpline or leave your details, and someone will help you arrange a consultation at the CION centre nearest you. One helpline serves every CION centre.
Call 1800 202 8726
Helpline open 24/7
Words you will hear
The vocabulary, in plain language
- Regimen
- A specific combination of drugs given in a set order and schedule. Named by the initials of its drugs.
- Anthracycline
- A family of chemotherapy drugs that adds benefit for higher-risk cancers and carries a small, dose-related heart risk.
- Taxane
- A family of chemotherapy drugs used in most breast cancer regimens. Commonly linked with tingling in the hands and feet.
- Cycle
- One round of treatment followed by a recovery period, repeated across the course.
- Adjuvant
- Given after surgery to lower the chance of the cancer returning. Neoadjuvant means the same treatment given before.
- Echocardiogram
- A heart ultrasound, often done before an anthracycline to check heart function.
Being straight with you
What this comparison cannot tell you
It cannot tell you which regimen you should have. That depends on the full detail of your pathology report, your heart and your general health, weighed by an oncologist who knows your case. Comparing your plan with a relative's usually misleads, because the cancers differ.
More cycles is not automatically better
Families sometimes worry that a shorter course means less effective treatment. For the right cancer it is the appropriate course, sparing side effects that would add little benefit. More treatment helps only where the cancer needs it.
The heart risk is real and monitored
Anthracyclines carry a small risk of heart effects that rises with the total dose received. It is the reason a heart check is usually done beforehand and why the dose is capped. It is weighed against the benefit, not ignored.
Timing within the course matters too
Some regimens are given at shorter intervals to deliver the same drugs over less time, with support to protect the blood count. Whether that suits you depends on your cancer and how you tolerate treatment, and it is part of the same conversation about which regimen to use.
Plans can change
New information, how you tolerate treatment, or a change in your health can lead your oncologist to adjust the regimen. That is careful treatment rather than indecision.
Ask the question that matters
Rather than asking which regimen is best in general, ask why this one was chosen for you and what would have made the other the better choice. That answer tells you far more than any comparison table.
Commonly believed
What families say about the number of cycles
Eight cycles must be stronger treatment than four.
The longer course is not simply a stronger version of the shorter one; it is a different regimen chosen for a different level of risk. For a lower-risk cancer, the shorter course is the appropriate treatment, not a weaker one.
My relative had a different regimen, so mine is wrong.
Regimen choice depends on node status, subtype, grade, heart health and age. Two similar-sounding cancers can reasonably need different treatment. Ask your oncologist why yours was chosen rather than comparing plans.
Leaving out the anthracycline means cutting corners.
Where its added benefit is small, avoiding its heart risk is a sound clinical decision. Oncologists leave it out deliberately for the right cancers, and include it where the benefit justifies the risk.
Side effects mean the chemotherapy is working better.
How severe your side effects are does not show how well the treatment is working against the cancer. Report side effects so they can be managed; their presence or absence is not a measure of effectiveness.
Questions we are asked
Common questions about regimen choice
Can I ask for the shorter course?
You can ask, and your oncologist should explain why they recommended what they did. If your cancer carries a higher risk, the longer course may offer meaningful extra benefit. It is a discussion about balancing benefit against side effects, not simply a preference.
Why do I need a heart scan?
Anthracycline-containing regimens carry a small risk to the heart, so its function is usually checked beforehand to make sure treatment is safe and to have a baseline. It is a routine precaution rather than a sign of a problem.
Is one regimen more effective than the other?
Each is effective for the cancers it suits. The anthracycline-containing course adds benefit for higher-risk disease; for lower-risk disease the shorter course performs well without the heart risk. Which is right depends on your cancer.
Will I lose my hair on either?
Hair loss is usual with both. Ask whether scalp cooling is available if keeping your hair matters to you, since it has to be arranged before treatment starts and does not suit every regimen.
Does the number of cycles affect my work?
A longer course means more months of treatment, so it affects planning around work and family more. Ask your team for the full schedule in writing so you can arrange leave and support for the whole course.
Can the regimen change partway through?
Yes, if you have significant side effects, if your heart function changes, or if new information emerges. Adjustments are made to keep treatment safe and effective, and your oncologist will explain any change.
Is a gene test relevant to this?
For some hormone sensitive, HER2 negative cancers, a gene test on the tumour helps decide whether chemotherapy adds benefit at all. Ask whether one applies to you before regimen choice is finalised.
Where can I read about the specific drugs?
Your oncology team will give you written information about each drug in your regimen, including side effects and what to report. Use that as your reference, and ask them about anything you read elsewhere.
Meet the Specialists
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Surgical Oncologist
Surgical Oncologist
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Surgical Oncologist
Radiation Oncologist
Radiation Oncologist
Radiation Oncologist
Hematologist
Surgical Oncologist
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Where to find us
Our centres in and around Hyderabad
Addressed by landmark, because that is how this city navigates. Each centre also names the areas it serves, so you can place it without a map. Consultation and day-care Chemotherapy run at every one of them.
Warangal
Vizag
Talk to our team
Speak to a breast cancer specialist
Call the helpline or leave your details, and someone will help you arrange a consultation at the CION centre nearest you. One helpline serves every CION centre.
Call 1800 202 8726
Helpline open 24/7
Sources
- Cancer Research UK — Chemotherapy for breast cancer
- National Cancer Institute — Breast cancer treatment (PDQ)
- Breast Cancer Now — Chemotherapy for breast cancer
This page is general information, not a prescription. Do not change or stop any treatment based on what you read here. If anything is worrying you, contact your own treating team — or call our helpline and we will help you reach the right specialist.